Sommer Bazuro, PhD, Chief Medical Officer at IPG Health, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance and Dr. Adriana Kahn, Yale School of Medicine chat about the ever-evolving breast cancer campaign space.

In light of the 2025 MM+M Media Summit, Deerfield Group’s head of media Bill Veltre talks to us about what’s on his radar.

Journalist and author of How to Menopause Tamsen Fadal sheds light on her new book, which guides women through perimenopause and menopause.

In this episode, we explore how the consumerization of healthcare has pharma thinking more like retailers. RVO Health’s Suzy Jackson joins us to talk about its new digital health division and what “direct-to-patient” really means for the patient experience. Plus, who’s driving this shift inside pharma, and the one piece of advice every brand should take into 2026.

Reporter Heerea Rikhraj reconnects with Grey Health chief creative officer Bruno Rebelo and planning director Astrid Kramm about what the agency has in the pipeline to support AstraZeneca throughout the NHL season.

Following a conversation about health data privacy, we have Titanium Award honoree Jamie-Lynn Sigler’s keynote address.

Listen to what medical marketing leaders had to say about the top industry trends before the 2025 MM+M Awards got underway.

MM+M Awards Jury Chair Meghan Rivera previews the year’s biggest night in medical marketing.

Supreme Group’s CEO Tom Donnelly and Pivot Design’s president Liz Kanter discuss the power of private equity partnerships, how they started working with private equity and how the partnerships have impacted their businesses.

MM+M offers a measured, nuanced response to the Trump administration’s public claim that Tylenol usage is linked to an increased rate of autism.

Recurring guest Andrea Palmer, the CEO of Publicis Health Media, as well as Brad Liebow, who recently jumped from Spark Foundry to become PHM’s first chief investment officer, discuss the agency’s plans for the future.

A healthcare exec answers your burning questions about what happens after people stop taking GLP-1s.

In this episode, we explore the story behind the Empathy Engine — Syneos Health Communications’ groundbreaking consumer data hub that's transforming the way healthcare brands connect with people.

Stephenie Atkins, senior director, brand lead product strategy and marketing at Incyte, to discuss HS Truths and how it serves to elevate the profile of HS as a disease state.

The medical marketer turned mental health warrior unveiled a new effort to further amplify the lived experiences of patients.

Lucid Diagnostics' chief technology and compliance officer Dr. Brian deGuzman discusses the company’s nationwide initiative to provide education and testing for esophageal precancer.

Explore the latest trends in HCP content consumption and how pharma marketers can adapt their strategies to reach their target audience effectively.

Stacia Garner, VP of marketing at Edwards Lifesciences, discusses the company’s partnership with the Los Angeles Rams to raise awareness of heart valve failure.

Pharma Editor Lecia Bushak spoke with Relevate Health’s Sam Glassenberg about its recent type 1 diabetes video game launch over the summer.